Albert Grass
Papers
1
Total Citations
40
H-Index
1
About
Dr. Albert Grass is a leading translational researcher in ovarian cancer genomics, with a particular focus on homologous recombination deficiency (HRD) as a predictive biomarker. His most-cited work, “Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort” (2022, 40 citations), provides critical insights into the diagnostic evaluation of HRD in a large, real-world patient population. By analyzing 514 ovarian carcinoma samples through next-generation sequencing—including BRCA1/BRCA2 and over 26,000 single-nucleotide polymorphisms—Dr. Grass demonstrated how comprehensive genomic profiling can guide targeted therapy strategies. This study has been instrumental in bridging the gap between laboratory research and clinical practice, helping clinicians identify patients most likely to benefit from PARP inhibitors. Dr. Grass’s contributions are shaping precision oncology, offering hope for more effective, personalized treatments in ovarian cancer. His work continues to influence both diagnostic standards and therapeutic decision-making, marking him as a rising authority in cancer biomarker research.
Research Focus
Key Achievements
Top Papers
- 1